Does Opium Consumption Have Shared Impact on Atherosclerotic Cardiovascular Disease and Cancer?
暂无分享,去创建一个
R. Malekzadeh | N. Sarrafzadegan | A. Ignaszewski | A. Mani | K. Turk-Adawi | K. Zendehdel | A. Vasheghani-Farahani | F. Masoudkabir | M. Toma | N. Yavari | Pegah Roayaei | Farzad Masoudkabir
[1] R. Malekzadeh,et al. Carcinogenicity of opium consumption. , 2020, The Lancet. Oncology.
[2] R. Malekzadeh,et al. Long-term opiate use and risk of cardiovascular mortality: results from the Golestan Cohort Study. , 2020, European journal of preventive cardiology.
[3] R. Malekzadeh,et al. Opium use and subsequent incidence of cancer: results from the Golestan Cohort Study , 2020, The Lancet. Global health.
[4] O. Mehrpour,et al. Opium use and cardiovascular diseases: a systematic review and meta-analysis , 2020, Critical reviews in toxicology.
[5] R. Malekzadeh,et al. Individual and Combined Effects of Environmental Risk Factors for Esophageal Cancer Based on Results From the Golestan Cohort Study. , 2019, Gastroenterology.
[6] R. D. de Boer,et al. Common risk factors for heart failure and cancer , 2019, Cardiovascular research.
[7] G. S. Sharma,et al. Disturbed homocysteine metabolism is associated with cancer , 2019, Experimental & Molecular Medicine.
[8] N. Shahrokhi,et al. Effects of Opium Addiction on Some Biochemical Factors in Diabetic Rats , 2018, Addiction & health.
[9] S. Asgary,et al. Opium Addiction and Ischemic Stroke in Isfahan, Iran: A Case-Control Study , 2017, European Neurology.
[10] R. Malekzadeh,et al. Opium Use and Risk of Pancreatic Cancer: A Prospective Cohort Study , 2017, Cancer Epidemiology, Biomarkers & Prevention.
[11] C. Mantzoros,et al. Adiponectin, lipids and atherosclerosis , 2017, Current opinion in lipidology.
[12] N. Sarrafzadegan,et al. Cardiovascular disease and cancer: Evidence for shared disease pathways and pharmacologic prevention. , 2017, Atherosclerosis.
[13] M. Moosazadeh,et al. Opium and bladder cancer: A systematic review and meta-analysis of the odds ratios for opium use and the risk of bladder cancer , 2017, PloS one.
[14] R. Afshari,et al. Opium Addiction and Risk of Laryngeal and Esophageal Carcinoma , 2017, Iranian journal of otorhinolaryngology.
[15] L. Jahangiry,et al. Outcomes and long-term survival of coronary artery surgery: The controversial role of opium as risk marker , 2016, World journal of cardiology.
[16] R. Malekzadeh,et al. Mortality from respiratory diseases associated with opium use: a population-based cohort study , 2016, Thorax.
[17] K. Zhao,et al. Preoperative peripheral plasma fibrinogen level is an independent prognostic marker in penile cancer , 2016, Oncotarget.
[18] N. Khanjani,et al. Can Opium Use Contribute to a Higher Risk of Colorectal Cancers? A Matched Case-control Study in Iran , 2016, Iranian journal of public health.
[19] A. Sayadi,et al. Opium addiction as an independent risk factor for coronary microvascular dysfunction: A case-control study of 250 consecutive patients with slow-flow angina. , 2016, International journal of cardiology.
[20] H. Ghaem,et al. Colorectal Cancer Mortality in Shiraz, Iran. , 2016, Asian Pacific journal of cancer prevention : APJCP.
[21] F. Hu,et al. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study , 2016, BMC Cancer.
[22] Mohammad R. Ostovaneh,et al. Opium use, cigarette smoking, and alcohol consumption in relation to pancreatic cancer , 2016, Medicine.
[23] R. Seemann,et al. Prognostic Impact of Pretreatment Plasma Fibrinogen in Patients with Locally Advanced Oral and Oropharyngeal Cancer , 2016, PloS one.
[24] M. R. Sadeghian,et al. The Effect of Smoking and Opium on Bladder Cancer in Yazd Province: A Case - Control Study , 2016 .
[25] B. Dutta,et al. Glycated Hemoglobin (HbA1c) Correlation with Severity of Coronary Artery Disease in Non-diabetic Patients - A Hospital based Study from North-Eastern India. , 2016, Journal of clinical and diagnostic research : JCDR.
[26] Parvinder Kumar,et al. Methylenetetrahydrofolate reductase C677T and methionine synthase A2756G gene polymorphisms and associated risk of cardiovascular diseases: A study from Jammu region , 2016, Indian heart journal.
[27] A. Blaes,et al. Shared Risk Factors in Cardiovascular Disease and Cancer , 2016, Circulation.
[28] P. Tan,et al. Evolving role of adiponectin in cancer-controversies and update , 2016, Cancer biology & medicine.
[29] Shan-shan Liang,et al. Hyperfibrinogenemia predicts poor prognosis in patients with advanced biliary tract cancer , 2016, Tumor Biology.
[30] Xiaoming Xie,et al. The preoperative plasma fibrinogen level is an independent prognostic factor for overall survival of breast cancer patients who underwent surgical treatment. , 2015, Breast.
[31] Chi-Chih Wang,et al. Factor VII promotes hepatocellular carcinoma progression through ERK-TSC signaling , 2015, Cell Death Discovery.
[32] A. Jafarian,et al. Surgical infrainguinal revascularization for peripheral arterial disease: factors affecting patency rate , 2015, Medical journal of the Islamic Republic of Iran.
[33] H. Harati,et al. The Mortality Rate of Myocardial Infraction Patients With and Without Opium Dependen , 2015, International journal of high risk behaviors & addiction.
[34] N. Khanjani,et al. Opium as a Risk Factor for Bladder Cancer: A Population-based Case-control Study in Iran. , 2015, Archives of Iranian medicine.
[35] N. Azdaki,et al. Elevated Plasma Homocysteine Concentration in Opium-Addicted Individuals , 2015, Addiction & health.
[36] Jingpu Shi,et al. Genetic polymorphism of MTHFR C677T and premature coronary artery disease susceptibility: A meta-analysis. , 2015, Gene.
[37] E. Ghaderi,et al. Occupation, smoking, opium, and bladder cancer: A case–control study , 2015, South Asian Journal of Cancer.
[38] Haijian Wu,et al. Circulating Adiponectin and Risk of Endometrial Cancer , 2015, PloS one.
[39] V. Bravatà. Controversial roles of methylenetetrahydrofolate reductase polymorphisms and folate in breast cancer disease , 2015, International journal of food sciences and nutrition.
[40] M. Khoshknab,et al. Survey of the Effect of Opioid Abuse on the Extent of Coronary Artery Diseases , 2014, Global journal of health science.
[41] M. Motamedi,et al. Opium Usage as an Etiologic Factor of Oral Cavity Cancer , 2014, The Journal of craniofacial surgery.
[42] Zhijian Yang,et al. Hemoglobin A1c Risk Score for the Prediction of Coronary Artery Disease in Subjects with Angiographically Diagnosed Coronary Atherosclerosis , 2014, Cellular Physiology and Biochemistry.
[43] M. Salarifar,et al. Opium Consumption and Mid-Term Outcome of Percutaneous Coronary Intervention in Men , 2014, The journal of Tehran Heart Center.
[44] W. Kim,et al. Association between obesity-related adipokines and colorectal cancer: a case-control study and meta-analysis. , 2014, World journal of gastroenterology.
[45] Ping Chen,et al. Value of fibrinogen and D-dimer in predicting recurrence and metastasis after radical surgery for non-small cell lung cancer , 2014, Medical Oncology.
[46] James H Doroshow,et al. Molecular mechanisms underlying chronic inflammation-associated cancers. , 2014, Cancer letters.
[47] L. Liebenberg,et al. Does cancer risk increase with HbA1c, independent of diabetes? , 2014, British Journal of Cancer.
[48] Navid Mohammadi,et al. Opium dependency and in-hospital outcome of acute myocardial infarction , 2014, Medical journal of the Islamic Republic of Iran.
[49] N. Sarrafzadegan,et al. Effects of opium consumption on cardiometabolic diseases , 2013, Nature Reviews Cardiology.
[50] M. Shokoohi,et al. The effect of opium addiction on serum adiponectin and leptin levels in male subjects: a case control study from Kerman Coronary Artery Disease Risk Factors Study (KERCADRS) , 2013, EXCLI journal.
[51] A. Shafiee,et al. Serum Uric Acid Is Not an Independent Risk Factor for Premature Coronary Artery Disease , 2013, Cardiorenal Medicine.
[52] R. Malekzadeh,et al. Opium Use and Risk of Mortality from Digestive Diseases: A Prospective Cohort Study , 2013, The American Journal of Gastroenterology.
[53] R. Malekzadeh,et al. Opium: An emerging risk factor for gastric adenocarcinoma , 2013, International journal of cancer.
[54] S. Aref,et al. Impact of serum adiponectin and leptin levels in acute leukemia , 2013, Hematology.
[55] G. Mosayebi,et al. Cytokine Profiles in Long-Term Smokers of Opium (Taryak) , 2013, Journal of addiction medicine.
[56] A. Haghdoost,et al. Relation of Opium Addiction with the Severity and Extension of Myocardial Infarction and Its Related Mortality , 2013, Addiction & health.
[57] M. Rezaeian,et al. The plasma levels of the cytokines in opium-addicts and the effects of opium on the cytokines secretion by their lymphocytes. , 2013, Immunology letters.
[58] N. Sarrafzadegan,et al. Opium decreases the age at myocardial infarction and sudden cardiac death: a long- and short-term outcome evaluation. , 2013, Archives of Iranian medicine.
[59] J. Manson,et al. A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. , 2013, Journal of the National Cancer Institute.
[60] M. Mohammadpour,et al. Evaluation of the role of opium addiction in acute myocardial infarction as a risk factor. , 2013, Caspian journal of internal medicine.
[61] Y. DeClerck,et al. Protumorigenic activity of plasminogen activator inhibitor-1 through an antiapoptotic function. , 2012, Journal of the National Cancer Institute.
[62] M. Rezvani,et al. Is opium addiction a risk factor for ischemic heart disease and ischemic stroke? , 2012, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.
[63] A. Salehi,et al. The relationship between coronary risk factors and coronary artery involvement based on angiogrpahy findings. , 2012 .
[64] S. Joukar,et al. Combination of opium smoking and hypercholesterolemia augments susceptibility for lethal cardiac arrhythmia and atherogenesis in rabbit. , 2012, Environmental toxicology and pharmacology.
[65] S. Hursting,et al. Growth Signals, Inflammation, and Vascular Perturbations: Mechanistic Links Between Obesity, Metabolic Syndrome, and Cancer , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[66] M. Najafi,et al. Does Analgesic Effect of Opium Hamper the Adverse Effects of Severe Coronary Artery Disease on Quality of Life in Addicted Patients? , 2012, Anesthesiology and pain medicine.
[67] T. Urano,et al. PAI‐1, progress in understanding the clinical problem and its aetiology , 2012, British journal of haematology.
[68] J. K. Kundu,et al. Emerging avenues linking inflammation and cancer. , 2012, Free radical biology & medicine.
[69] R. Malekzadeh,et al. Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50 000 adults in Iran , 2012, BMJ : British Medical Journal.
[70] Qin Yang,et al. Association between polymorphism of methylenetetrahydrofolate reductase (MTHFR) C677T and risk of myocardial infarction: a meta-analysis for 8,140 cases and 10,522 controls. , 2011, Archives of medical research.
[71] V. Ploplis. Effects of altered plasminogen activator inhibitor-1 expression on cardiovascular disease. , 2011, Current drug targets.
[72] A. Rahimi-Foroushani,et al. Opium consumption and coronary atherosclerosis in diabetic patients: a propensity score-matched study. , 2011, Planta medica.
[73] P. Marino,et al. High fibrinogen level is an independent predictor of presence and extent of coronary artery disease among Italian population , 2011, Journal of Thrombosis and Thrombolysis.
[74] A. Mirzazadeh,et al. Abrupt opium discontinuation has no significant triggering effect on acute myocardial infarction , 2011, Journal of cardiovascular medicine.
[75] E. Amini,et al. Opium consumption and risk of bladder cancer: A case-control analysis. , 2010, Urologic oncology.
[76] M. Masoomi,et al. The Relationship of Opium Addiction with Coronary Artery Disease , 2010, International journal of preventive medicine.
[77] M. Salarifar,et al. Opium consumption in men and diabetes mellitus in women are the most important risk factors of premature coronary artery disease in Iran. , 2010, International journal of cardiology.
[78] R. Krasuski,et al. Impact of Fibrinogen Levels on Angiographic Progression and 12-Year Survival in the Armed Forces Regression Study , 2010, Angiology.
[79] G. Bu,et al. LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy , 2010, Proceedings of the National Academy of Sciences.
[80] S. Joukar,et al. Passive opium smoking does not have beneficial effect on plasma lipids and cardiovascular indices in hypercholesterolemic rabbits with ischemic and non-ischemic hearts. , 2010, Journal of ethnopharmacology.
[81] R. Malekzadeh,et al. Cohort Profile: The Golestan Cohort Study--a prospective study of oesophageal cancer in northern Iran. , 2010, International journal of epidemiology.
[82] S. Joukar,et al. The Effect of Passive Opium Smoking on Cardiovascular Indices of Rabbits with Normal and Ischemic Hearts , 2010, The open cardiovascular medicine journal.
[83] Clemens Tempfer,et al. Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter study. , 2009, The oncologist.
[84] J. Fichna,et al. The Influence of Opioids on Urokinase Plasminogen Activator on Protein and mRNA Level in MCF‐7 Breast Cancer Cell Line , 2009, Chemical biology & drug design.
[85] Alberto Mantovani,et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. , 2009, Carcinogenesis.
[86] A. Mohammadi,et al. Effect of opium addiction on lipid profile and atherosclerosis formation in hypercholesterolemic rabbits. , 2009, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
[87] E. Arısan,et al. Serum Adipocytokine Levels in Prostate Cancer Patients , 2009, Urologia Internationalis.
[88] Serap Yıldırım,et al. Serum adiponectin levels in patients with esophageal cancer. , 2008, Japanese journal of clinical oncology.
[89] S. Asgary,et al. Lipids in Health and Disease , 2008 .
[90] E. Hajizadeh,et al. Cultural barriers in the education of cardiovascular disease patients in Iran. , 2008, International nursing review.
[91] P Boffetta,et al. Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran , 2008, British Journal of Cancer.
[92] M. Salarifar,et al. The association of opium with coronary artery disease , 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[93] M. Karbakhsh,et al. Acute opiate overdose in Tehran: the forgotten role of opium. , 2007, Addictive behaviors.
[94] A. Laraqui,et al. Thermolabile Methylenetetrahydrofolate Reductase C677T Polymorphism and Homocysteine Are Risk Factors for Coronary Artery Disease in Moroccan Population , 2007, Journal of biomedicine & biotechnology.
[95] M. Abtahi. EVALUATION OF BLADDER CANCER IN OPIUM ADDICTED PATIENTS IN THE KERMAN PROVINCE, IRAN FROM 1999 TO 2003 , 2006 .
[96] Dong Kun Lee,et al. Activation of the canonical Wnt/beta-catenin pathway enhances monocyte adhesion to endothelial cells. , 2006, Biochemical and biophysical research communications.
[97] Chuanshu Huang,et al. Inflammation, a Key Event in Cancer Development , 2006, Molecular Cancer Research.
[98] M. Ahmadinejad,et al. EVALUATION OF BLADDER CANCER IN OPIUM ADDICTED PATIENTS IN THE KERMAN PROVINCE, IRAN, FROM 1999 TO 2003 , 2005 .
[99] B. Sarwar,et al. A Case-Control Study of Effect of Opium Addiction on Myocardial Infarction , 2005 .
[100] K. G. Z. Izadimoud. IS OPIUM ADDICTION A RISK FACTOR FOR ACUTE MYOCARDIAL INFARCTION , 2005 .
[101] H. Nagawa,et al. Plasma adiponectin and gastric cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[102] J. Schlesselman,et al. Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk. , 2004, International journal of oncology.
[103] Kongpetch Kulsudjarit. Drug Problem in Southeast and Southwest Asia , 2004, Annals of the New York Academy of Sciences.
[104] M. Khaksari,et al. Effects of opium addiction on some serum factors in addicts with non‐insulin‐dependent diabetes mellitus , 2004, Addiction biology.
[105] C. Mantzoros,et al. Adiponectin and breast cancer risk. , 2004, The Journal of clinical endocrinology and metabolism.
[106] D. Richel,et al. Coagulation factors VIIa and Xa inhibit apoptosis and anoikis , 2004, Oncogene.
[107] A. Khamesipour,et al. Opium and risk of laryngeal cancer , 2003, The Laryngoscope.
[108] T. Hembrough,et al. Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. , 2003, Cancer research.
[109] V. Salomaa,et al. Hemostatic Factors as Predictors of Coronary Events and Total Mortality: The FINRISK ’92 Hemostasis Study , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[110] J. Plutzky. Inflammatory pathways in atherosclerosis and acute coronary syndromes. , 2001, The American journal of cardiology.
[111] C. Bode,et al. Regulation of PAI-1 expression by genetic polymorphisms. Impact on atherogenesis. , 2001, Thrombosis research.
[112] M. Duffy. Urokinase-type plasminogen activator: a potent marker of metastatic potential in human cancers. , 2001, Biochemical Society transactions.
[113] V. Salomaa,et al. Prospective Study of Fibrinolytic Factors and Incident Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[114] Alberto Mantovani,et al. Inflammation and cancer: back to Virchow? , 2001, The Lancet.
[115] J. Townend,et al. Homocysteine and atherothrombosis--mechanisms for injury. , 2000, European heart journal.
[116] M. Skobe,et al. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization , 1998, Nature Medicine.
[117] K. Becker,et al. Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. , 1994, Cancer research.
[118] T. Meade,et al. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study , 1993, The Lancet.
[119] N. Day,et al. Oesophageal cancer studies in the caspian littoral of Iran: Some residual results, including opium use as a risk factor , 1985, International journal of cancer.
[120] S. Vesselinovitch,et al. Opium: A potential urinary bladder carcinogen in man , 1979, Cancer.
[121] P. Novak,et al. [The effect of smoking on the quality of life enhancement following prosthetic rehabilitation in head and neck cancer patients who underwent surgical treatment]. , 2017, Orvosi hetilap.
[122] M. Shabani,et al. Impact of Opium Addiction on Levels of Pro- and Anti-inflammatory Cytokines after Surgery , 2016, Addiction & health.
[123] H. Shafi,et al. Age distribution types of bladder cancers and their relationship with opium consumption and smoking , 2015, Caspian journal of internal medicine.
[124] R. Malekzadeh,et al. Neglected role of hookah and opium in gastric carcinogenesis: A cohort study on risk factors and attributable fractions , 2014, International journal of cancer.
[125] Reza Malekpour-afshar,et al. Serum Level of Plasminogen Activator Inhibitor Type-1 in Addicted Patients with Coronary Artery Disease , 2014, Addiction & health.
[126] N. Khanjani,et al. Frequency of Opium Addiction in Patients with Ischemic Stroke and Comparing their Cerebrovascular Doppler Ultrasound Changes to Non-Addicts , 2013, Addiction & health.
[127] M. Shokoohi,et al. The effect of opium addiction on arrhythmia following acute myocardial infarction. , 2012, Acta medica Iranica.
[128] B. Eshrati,et al. Prominent bladder cancer risk factors in Iran. , 2010, Asian Pacific journal of cancer prevention : APJCP.
[129] M. Esfandbod,et al. Can opium abuse be a risk factor for carotid stenosis in patients who are candidates for coronary artery bypass grafting? , 2010, Cardiology journal.
[130] A. Mirzazadeh,et al. Opium addiction and severity of coronary artery disease: a case-control study , 2010, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.
[131] D. Lu,et al. Treatment of solid tumors and metastases by fibrinogen-targeted anticancer drug therapy. , 2007, Medical hypotheses.
[132] S. Darvish,et al. COMPARISON OF SPECIFICATIONS, SHORT TERM OUTCOME AND PROGNOSIS OF ACUTE MYOCARDIAL INFARCTION IN OPIUM DEPENDENT PATIENTS AND NONDEPENDENTS , 2006 .
[133] A. Nourbakhsh,et al. OPIUM USE IN TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER , 2006 .
[134] D. Labuda,et al. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. , 2004, Blood.
[135] H. Dvorak,et al. Fibrin as a component of the tumor stroma: origins and biological significance , 2004, Cancer and Metastasis Reviews.
[136] L. Gachkar,et al. Is bladder cancer more common among opium addicts? , 2004, Urology journal.
[137] J. Guilbert. The world health report 2002 - reducing risks, promoting healthy life. , 2003, Education for health.
[138] K. Matsuo,et al. Methionine Synthase Reductase Gene A66G Polymorphism is Associated with Risk of Colorectal Cancer. , 2002, Asian Pacific journal of cancer prevention : APJCP.
[139] H. Nasri,et al. COMPARISON OF PLASMA FIBRINOGEN LEVEL IN OPIUM ADDICT MEN WITH NON-ADDICT MEN , 2002 .